SARM1 and amyotrophic lateral sclerosis: In this regard, we speculate that TDP-43 dysregulation in ALS may confer an increased susceptibility to activation of the Wallerian pathway via SARM1, causing NAD+ depletion (and consequently ATP depletion), axonal degeneration, NMJ denervation and MN loss.